Bicocca Open Archive

Logo unimib boa
BONFANTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.561
EU - Europa 6.194
AS - Asia 2.388
SA - Sud America 48
AF - Africa 24
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.434
IT - Italia 1.811
DE - Germania 1.225
SG - Singapore 1.103
IE - Irlanda 934
SE - Svezia 860
RU - Federazione Russa 719
HK - Hong Kong 524
CN - Cina 300
GB - Regno Unito 209
VN - Vietnam 146
ID - Indonesia 98
UA - Ucraina 91
CA - Canada 90
IN - India 88
FI - Finlandia 87
FR - Francia 54
RO - Romania 48
TR - Turchia 41
NL - Olanda 37
MX - Messico 34
AT - Austria 27
CZ - Repubblica Ceca 20
CO - Colombia 18
BE - Belgio 17
PH - Filippine 16
BR - Brasile 15
ES - Italia 15
JP - Giappone 14
IR - Iran 11
KR - Corea 9
CL - Cile 8
DK - Danimarca 7
BG - Bulgaria 6
KE - Kenya 6
MY - Malesia 6
AU - Australia 5
NZ - Nuova Zelanda 5
PK - Pakistan 5
PL - Polonia 5
SC - Seychelles 5
ZA - Sudafrica 5
AR - Argentina 4
CH - Svizzera 4
GR - Grecia 4
TH - Thailandia 4
TW - Taiwan 4
BY - Bielorussia 3
JO - Giordania 3
KZ - Kazakistan 3
MU - Mauritius 3
SA - Arabia Saudita 3
AM - Armenia 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
LT - Lituania 2
MM - Myanmar 2
NG - Nigeria 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
CR - Costa Rica 1
EC - Ecuador 1
EU - Europa 1
JM - Giamaica 1
KG - Kirghizistan 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
Totale 18.227
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.462
Frankfurt am Main 1.135
Singapore 966
Dublin 908
Fairfield 768
Chandler 739
New York 583
Hong Kong 522
Ashburn 414
Wilmington 403
Woodbridge 400
Princeton 383
Milan 374
Houston 327
Santa Clara 273
Seattle 273
Cambridge 218
Altamura 204
Lawrence 178
San Diego 113
Dong Ket 109
Jakarta 98
London 84
Shanghai 82
Jacksonville 73
Rome 61
Andover 60
Chicago 58
Helsinki 58
Guangzhou 52
Dearborn 50
Boardman 47
Falls Church 44
Galati 43
Pune 41
Toronto 40
Fremont 36
Monza 33
Beijing 30
Nanjing 29
Florence 26
Vienna 26
Los Angeles 24
Norwalk 24
Lissone 23
Washington 18
Brno 17
Cuauhtémoc 17
Bogotá 16
Naples 16
Palermo 16
Brussels 15
Lappeenranta 15
Turin 15
Brescia 14
Istanbul 14
Lachine 14
Ottawa 14
Dallas 13
Redmond 13
Carate Brianza 12
Hangzhou 12
Padova 12
Shenzhen 12
Busto Arsizio 11
Groningen 11
Jinan 11
Kilburn 10
Kocaeli 10
Kolkata 10
Pisa 10
Romola 10
Acquafredda 9
Bari 9
Huizen 9
Hyderabad 9
Bologna 8
Catania 8
Desio 8
Mexico City 8
Tianjin 8
Amsterdam 7
Bergamo 7
Cesate 7
Moscow 7
Mumbai 7
San Mateo 7
Shenyang 7
Casorate Primo 6
Ferrara 6
Genoa 6
Mariano Comense 6
Melzo 6
Munich 6
Nairobi 6
Nanchang 6
Rio de Janeiro 6
Sacramento 6
Verona 6
Vimercate 6
Totale 13.449
Salva come PNG Salva come JPEG
Nome #
Methotrexate inhibits SARS-CoV-2 virus replication "in vitro" 393
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 309
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 231
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 213
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 208
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting 200
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 194
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 194
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 188
Delirium in Patients with SARS‐CoV‐2 Infection: A Multicenter Study 185
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 181
An immune-based biomarker signature is associated with mortality in COVID-19 patients 179
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 172
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 171
A second update on mapping the human genetic architecture of COVID-19 169
High rates of 30-day mortality in patients with cirrhosis and COVID-19 168
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 166
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 165
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 164
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 162
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 162
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 160
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 157
Mapping the human genetic architecture of COVID-19 154
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 153
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) 151
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy 151
Alternative pre-analytical strategies for SARS CoV 2 RNA detection 150
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 146
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 142
Infezione disseminata da Mycobacterium avium complex con batteriemia persistente in un paziente AIDS-presenter [Disseminated Mycobacterium avium complex infection with persistent bacteremia in an AIDS-presenter patient] 141
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 141
HIV and metabolic syndrome - A comparison with the general population 137
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 137
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 133
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 131
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 130
Anti-SARS-CoV-2 IgG antibodies induced by the BNT162b2 mRNA vaccine is age-dependent and influenced by a previous natural SARS-CoV-2 infection 126
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 125
Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study 125
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 122
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study 122
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 122
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 120
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 118
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID study 117
Streptococcus agalactiae infective endocarditis complicated by multiple mycotic hepatic aneurysms and massive splenic infarction: A case report 116
The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: A randomized multicentric study 115
Frailty index predicts poor outcome in COVID-19 patients 113
Assessing the mortality risk in older patients hospitalized with a diagnosis of sepsis: the role of frailty and acute organ dysfunction 113
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 112
Beware of biases in observational studies on anti-spike monoclonal antibodies 109
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 108
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible from the STOPSHIV Project Cohort 106
Weight gain: A possible side effect of all antiretrovirals 103
Being a Doctor Will Never Be the Same After the COVID-19 Pandemic 101
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 97
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 95
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 95
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 93
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 92
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 92
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 91
Steroids in severe COVID-19 patients: A retrospective analysis on the first pandemics in Lombardy 91
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 90
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 90
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 90
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 90
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 89
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients 89
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: A longitudinal study 88
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 88
Atrial Fibrillation Incidence in SARS-COV-2 Infected Patients: Predictors and Relationship with in-Hospital Mortality 87
Pillars of long-term antiretroviral therapy success 86
Factors Associated With Weight Gain in People Treated With Dolutegravir 86
Factors associated with hospital admission for COVID-19 in HIV patients 86
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 84
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 83
Osteonecrosis in human immunodeficiency virus (HIV)-infected patients: A multicentric case-control study 83
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 81
Compassionate Use of Remdesivir in Children With Severe COVID-19 80
Reply to: Hultström et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19 80
A multidisciplinary approach to screen the post-COVID-19 conditions 78
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 78
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: A budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy) 77
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 77
Atrial fibrillation and clinical outcomes in a cohort of hospitalized patients with sars-cov-2 infection and chronic kidney disease 75
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 74
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 74
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project 72
Disuguaglianze sanitarie e malattie infettive:molto ancora da fare 70
Long pentraxin 3 (PTX3) levels predict death, intubation and thrombotic events among hospitalized patients with COVID-19 70
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 68
HEFFICON: HIV effectiveness Italian conference 68
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 67
Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile Infections 67
Il linfoma di Hodgkin nei soggetti con infezione da HIV 66
Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART 66
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 65
HIV disease treatment in the era of HAART 65
Totale 12.254
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.823
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020483 0 0 0 31 32 55 31 34 43 23 99 135
2020/20213.841 91 157 231 316 313 409 247 383 517 392 329 456
2021/20222.848 305 318 311 238 160 206 116 201 169 123 192 509
2022/20234.463 584 1.066 439 386 356 704 98 233 288 68 132 109
2023/20243.812 149 115 222 136 473 917 617 127 356 146 79 475
2024/20252.863 643 1.401 679 140 0 0 0 0 0 0 0 0
Totale 19.127